For DEFA5, the expression levels in early-stage cancer patients (median: 3.41 [EU], range: 0–138.00 [EU]) were comparable to patients with late-stage cancer (median: 3.57 [EU], range: 0–61.73 [EU]) (p = ns) and thus were comparable to those of IID patients (Figure 3D). The gene discussed is DEFA5; the disease is cancer.